Abstract
These studies characterized the profile of AhR and ARNT expression in primary splenocytes and purified splenic B cells after cellular activation with lipopolysaccharide (LPS). LPS treatment of mouse splenocytes markedly increased the magnitude of both AhR and ARNT steady state mRNA expression. AhR mRNA expression peaked at 8 hr post-LPS activation and was increased by ∼5-fold compared with freshly isolated splenocytes (i.e., time 0). ARNT mRNA expression began to increase at 8 hr postactivation, peaked at approximately 48 hr and was increased by approximately 4-fold when compared with nonactivated splenocytes at time 0. Western blotting also demonstrated an increase in the relative magnitude of both the AhR and ARNT proteins in LPS activated splenocytes. Likewise, the presence of the AhR, ARNT and cytochrome P450IA1 (CYP1A1) proteins were also detected in purified primary splenic B cells, and the magnitude of protein expression was enhanced in LPS activated splenic B cells at 12 and 24 hr relative to time matched controls for each of these proteins. In summary, these findings suggest that on LPS activation the magnitude of AhR and ARNT mRNA and protein increases in both splenocytes and purified primary splenic B cells. Moreover, because the increase in the relative magnitude of CYP1A1 protein in response to LPS occurred in the absence of exogenous AhR ligand, these results suggest that B-cell activation is sufficient to induce AhR nuclear translocation and binding to dioxin-responsive elements in the promoter region of AhR-responsive genes.
Footnotes
-
Send reprint requests to: Dr. Norbert Kaminski, Dept. of Pharmacology and Toxicology, B-330 Life Sciences Bldg., Michigan State University, East Lansing, Michigan 48824, phone: 517-353-3786, fax: 517-353-8915, e-mail: kamins11{at}pilot.msu.edu
-
↵1 This study was supported, in part, by funds from NIEHS Grants ES07255 and ES02520. This work was recently presented as abstract number 1506 at the 37th Annual Society of Toxicology Meeting in Seattle, Washington, on March 4, 1998.
- Abbreviations:
- AhR
- aryl hydrocarbon receptor
- ARNT
- aryl hydrocarbon receptor nuclear translocator
- CYP1A1
- cytochrome P450IA1
- DRE
- dioxin-responive enhancer
- EMSA
- electrophoretic mobility shift assay
- FACS
- flow-activated cell sorter
- FITC
- fluorescein isothiocyanate
- hsp90
- heat shock protein 90
- LPS
- lipopolysaccharide
- mRNA
- messenger RNA
- R-PE
- R-phycoerythin
- RT-PCR
- reverse transcriptase-polymerase chain reaction
- TCDD
- 2,3,7,8-tetrachlorodibenzo-p-dioxin
- Received September 23, 1998.
- Accepted July 15, 1998.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|